National Bulk Drug Procurement Round 12 to Begin Bidding in Shanghai

Deep News07-31

On July 31st, the 12th round of nationally organized bulk drug procurement will open for bidding in Shanghai, with bidding companies starting to enter the venue and submit quotation materials from 7:30 AM.

This procurement round includes 65 types of drugs, covering commonly used medications in areas such as anti-infection, anti-tumor, anti-thrombosis, blood glucose lowering, blood pressure lowering, blood lipid lowering, rheumatology and immunology, and anti-inflammatory and analgesic treatments.

At the bidding site, institutions including Bank of China, China Export & Credit Insurance Corporation, China Merchants Bank, Shanghai Pudong Development Bank, Bank of Shanghai, and the China Drug Price Registration System are introducing and providing financial support services such as "procurement loans," "traceability code loans," and "drug price registration" to bidding companies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment